Trupanion (TRUP) Aktienübersicht
Trupanion, Inc. bietet zusammen mit seinen Tochtergesellschaften in den Vereinigten Staaten, Kanada und Kontinentaleuropa Krankenversicherungen für Katzen und Hunde auf Abonnementbasis an. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 1/6 |
| Künftiges Wachstum | 1/6 |
| Vergangene Leistung | 5/6 |
| Finanzielle Gesundheit | 4/6 |
| Dividenden | 0/6 |
Belohnungen
Risikoanalyse
TRUP unsere Risikoprüfungen bestanden.
TRUP Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Trupanion, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$25.00 |
| 52-Wochen-Hoch | US$46.98 |
| 52-Wochen-Tief | US$21.16 |
| Beta | 1.45 |
| 1 Monat Veränderung | -18.06% |
| 3 Monate Veränderung | 5.71% |
| 1 Jahr Veränderung | -42.48% |
| 3 Jahre Veränderung | -15.91% |
| 5 Jahre Veränderung | -69.38% |
| Veränderung seit IPO | 119.30% |
Aktuelle Nachrichten und Updates
Narrative-Update • Sep 10
TRUP: Execution On Margin Discipline Will Drive Long Term Upside
The analyst price target for Trupanion has been revised lower by $3 to $34.25 as analysts factor in softer revenue growth, slightly thinner projected profit margins, and a reduced future P/E assumption, along with recent downgrades and cautious commentary on the company's operating backdrop. Analyst Commentary Recent research on Trupanion highlights a mixed but increasingly cautious tone, with valuation and execution closely tied to how the company handles a slower pet health demand backdrop and competitive pressure.
Narrative-Update • Aug 26
TRUP: Lower Catastrophe Exposure Will Support Future Repricing As Demand Stabilizes
Analysts have trimmed Trupanion's fair value estimate from $45.00 to $42.00 as they factor in tougher pet insurance demand conditions, including weaker U.S. puppy vet visits and pressure on balancing premium growth with member retention and new-pet acquisition. Analyst Commentary Recent Street research on Trupanion highlights a mix of caution and optimism, with several firms refining their views as they reassess pet insurance demand, pricing power, and long term member growth.Seeking Alpha • Aug 14
Trupanion: Profitable At Last, But Still Too Expensive To Buy (Upgrade)
Summary Trupanion’s estimated economic combined ratio improved to 98.5% in H1 2026, extending the underwriting profitability first achieved in 2025. Operating leverage and lower acquisition costs drove much of the improvement, while the H1 loss ratio also declined to 71.0% from 72.1%. Management’s 2026 guidance could imply $32–$40 million of net income, providing stronger evidence that scale is finally translating into profitability. Valuation remains demanding at more than 30x estimated 2026 earnings under my scenarios, limiting the attractiveness of the shares at current prices. I upgrade Trupanion from Sell to Hold as improving underwriting economics weaken the bearish case, although the valuation still prevents a Buy. Read the full article on Seeking AlphaRecent updates
Narrative-Update • Sep 10
TRUP: Execution On Margin Discipline Will Drive Long Term Upside
The analyst price target for Trupanion has been revised lower by $3 to $34.25 as analysts factor in softer revenue growth, slightly thinner projected profit margins, and a reduced future P/E assumption, along with recent downgrades and cautious commentary on the company's operating backdrop. Analyst Commentary Recent research on Trupanion highlights a mixed but increasingly cautious tone, with valuation and execution closely tied to how the company handles a slower pet health demand backdrop and competitive pressure.Narrative-Update • Aug 26
TRUP: Lower Catastrophe Exposure Will Support Future Repricing As Demand Stabilizes
Analysts have trimmed Trupanion's fair value estimate from $45.00 to $42.00 as they factor in tougher pet insurance demand conditions, including weaker U.S. puppy vet visits and pressure on balancing premium growth with member retention and new-pet acquisition. Analyst Commentary Recent Street research on Trupanion highlights a mix of caution and optimism, with several firms refining their views as they reassess pet insurance demand, pricing power, and long term member growth.Seeking Alpha • Aug 14
Trupanion: Profitable At Last, But Still Too Expensive To Buy (Upgrade)
Summary Trupanion’s estimated economic combined ratio improved to 98.5% in H1 2026, extending the underwriting profitability first achieved in 2025. Operating leverage and lower acquisition costs drove much of the improvement, while the H1 loss ratio also declined to 71.0% from 72.1%. Management’s 2026 guidance could imply $32–$40 million of net income, providing stronger evidence that scale is finally translating into profitability. Valuation remains demanding at more than 30x estimated 2026 earnings under my scenarios, limiting the attractiveness of the shares at current prices. I upgrade Trupanion from Sell to Hold as improving underwriting economics weaken the bearish case, although the valuation still prevents a Buy. Read the full article on Seeking AlphaNarrative-Update • Aug 08
TRUP: Capital Returns And Margin Focus Will Drive Long Term Upside
For Trupanion, the analyst price target has been trimmed to $37.25 from $39.75 as analysts factor in a slightly higher discount rate and more modest profit margins in their models, even as revenue growth assumptions and the implied future P/E move higher. Analyst Commentary Recent Street research on Trupanion shows a mix of optimism on execution and caution on risk, which helps explain the reset in price targets around the stock.Narrative-Update • Jul 15
TRUP: Lower Catastrophe Exposure Will Support Long-Term Repricing Potential
For Trupanion, the analyst price target in this narrative framework has shifted lower from $52.00 to $45.00. This reflects analyst adjustments to long term revenue growth, profit margin expectations, and the future P/E multiple following recent catastrophe related commentary.
Narrative-Update • Jun 30
TRUP: Loyalty And Margin Execution Will Shape Prospective Earnings Upside
Trupanion's updated analyst price target has moved from $31.00 to $28.00 as analysts factor in slightly higher discount rates, a more moderate revenue growth outlook, and an adjusted future P/E assumption, while also reflecting recent Street target cuts. Analyst Commentary Recent Street commentary on Trupanion reflects a more cautious tone, with several bearish analysts trimming price targets and reassessing assumptions around growth, valuation, and execution risk.Narrative-Update • Jun 16
TRUP: Recalibrated Expectations And Improved Margins Will Support Long-Term Repricing
Trupanion's analyst price target has been reduced by $7 to $45. Analysts attribute the revision to updated assumptions around revenue growth, profit margins and future P/E multiples.Narrative-Update • Jun 01
TRUP: Rebased P/E And Margin Assumptions Will Support Long Term Upside
Trupanion's analyst price target is updated from $46.25 to $39.75 as analysts factor in refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations, reflected in recent Street research cuts from BofA, Cantor Fitzgerald, and Stifel. Analyst Commentary Recent Street research indicates that the lower price targets are tied to refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations.Narrative-Update • May 13
TRUP: Recalibrated Expectations And Higher Future P/E Will Support Long-Term Repricing
Analysts have lowered their fair value estimate for Trupanion from $63.00 to $52.00, citing updated price targets from several firms along with adjustments to discount rates, revenue growth, profit margin assumptions, and the stock's future P/E multiple. Analyst Commentary Recent Street research on Trupanion has centered on revised price targets that reflect updated assumptions for growth, margins, and valuation multiples.Narrative-Update • Apr 22
TRUP: Clustered Price Cuts And P/E Reset Will Shape Future Returns
Trupanion's updated analyst price target has been reduced by a mid single digit dollar amount, with analysts pointing to recently lowered targets from several firms, alongside only modest tweaks to long term revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent Street research on Trupanion has centered on a series of price target reductions, with cuts ranging from low single digit dollar amounts up to a $15 move.Narrative-Update • Apr 08
TRUP: Revised P/E And Margin Assumptions Will Support Future Earnings Power
Trupanion's updated analyst price target has shifted from $42.00 to $31.00 as analysts factor in different assumptions for future revenue growth, profitability and P/E expectations following several recent target cuts across the Street. Analyst Commentary Recent Street research on Trupanion has centered on a series of lower price targets, with several bearish analysts trimming their expectations within a relatively short time frame.Narrative-Update • Mar 25
TRUP: Rebased P/E Expectations Will Support Long Term Upside Potential
Narrative Update on Trupanion The analyst price target for Trupanion has been reduced by a combined $26, as several firms revisited their models and pricing assumptions. This led to a lower implied future P/E while keeping the fair value estimate steady at $46.25.Narrative-Update • Mar 10
TRUP: Reset Expectations And Higher Future P/E Will Drive Long-Term Repricing
Trupanion's updated $63.0 analyst price target reflects modestly tempered expectations for revenue growth and profit margin, with analysts citing recent target reductions from several firms as they reassess the stock's risk and return trade off. Analyst Commentary Recent Street research on Trupanion clusters around lower price targets, but the tone is not uniformly negative.Narrative-Update • Feb 24
TRUP: Long Term Profitability Assumptions Will Support Future Upside Potential
Analysts have reduced their Trupanion price targets by approximately $10 to $46.25, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following recent research updates from multiple firms. Analyst Commentary Recent research updates on Trupanion point to a mix of optimism about the long term opportunity and caution about the execution and valuation risks in the near term.Narrative-Update • Feb 09
TRUP: Higher Future P/E Assumptions Will Support A Stronger Long-Term Repricing
Analysts have reduced their Trupanion price target by about $4 to US$63, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E as the key drivers of the change. Analyst Commentary Bullish analysts are refining their views on Trupanion as they revisit key valuation inputs such as fair value estimates, discount rates, revenue assumptions, profit margins and future P/E levels.Narrative-Update • Jan 25
TRUP: Revised P/E Assumptions Will Support Long Term Earnings Power
Analysts have reduced their price targets on Trupanion by $8, citing updated assumptions for revenue growth, profit margin and future P/E, which modestly adjust the risk and return profile they see for the stock. Analyst Commentary Bearish analysts cutting their price targets by $8 are signaling a more cautious stance on Trupanion, driven by updated assumptions for revenue growth, profit margin and future P/E.Narrative-Update • Jan 11
TRUP: Future Margin Gains And Share Discipline Will Support Long Term Earnings Power
Analysts are maintaining a US$42.00 price target for Trupanion, with small adjustments to revenue growth, profit margin assumptions and a lower future P/E helping to fine tune their outlook rather than reset it. What's in the News Trupanion reported that, between July 1 and September 30, 2025, it did not repurchase any shares under its existing program and has completed total buybacks of 95,021 shares for US$5.75 million, representing 0.23% of shares under the buyback announced on April 30, 2021 (company filing).Narrative-Update • Dec 27
TRUP: Future Margin Expansion Will Support Strengthening Long Term Earnings Power
Analysts have modestly maintained their price target on Trupanion at approximately $42.00, citing slightly stronger expectations for revenue growth, incremental profit margin improvement, and a marginally lower future price to earnings multiple that together support the current valuation stance. What's in the News Updated full year 2025 guidance now calls for total revenue of $1.433 billion to $1.439 billion and subscription revenue of $986 million to $989 million, implying roughly 15% year over year subscription growth at the midpoint (company guidance).Narrative-Update • Dec 12
TRUP: Future Margin Recovery Will Support Strengthening Long Term Earnings Power
Analysts have modestly reduced their price target on Trupanion from 45.00 dollars to 42.00 dollars. This reflects more conservative assumptions for revenue growth, profit margins, and valuation multiples, despite a largely unchanged risk outlook.Narrative-Update • Aug 10
Increasing Pet Ownership And Data Analytics Will Expand Market
The consensus price target for Trupanion has increased to $59.67 as analysts assign a higher future P/E multiple despite a modest decline in net profit margin, signaling greater optimism about its growth prospects. Valuation Changes Summary of Valuation Changes for Trupanion The Consensus Analyst Price Target has significantly risen from $53.00 to $59.67.Neues Narrative • May 27
Global Expansion And Pricing Precision Will Shape Pet Markets
Enhanced pricing strategies, technology upgrades, and disciplined underwriting are driving margin expansion, higher operational efficiency, and more sustainable long-term earnings.Analyseartikel • May 13
Trupanion, Inc. (NASDAQ:TRUP) Looks Just Right With A 26% Price Jump
Trupanion, Inc. ( NASDAQ:TRUP ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...Analyseartikel • Feb 16
There's Reason For Concern Over Trupanion, Inc.'s (NASDAQ:TRUP) Price
When close to half the companies in the Insurance industry in the United States have price-to-sales ratios (or "P/S...Seeking Alpha • Dec 13
Trupanion: High Costs And Price Hikes Are Reasons To Avoid This Pet Insurer
Summary Trupanion's Q3'24 revenue grew 15% YoY to $327.5M, driven mainly by price hikes, but EPS missed estimates by $0.46. Subscription adjusted operating income surged 66% to $30.8M, improving margins, but new pet growth deceleration raises concerns. Expansion into Germany and Switzerland offers growth opportunities, but North American profitability and competitive pressures remain critical challenges. Trupanion faces risks from unsustainable price hikes, growing veterinary inflation, and higher acquisition costs. Its strategy of ramping up pet acquisition spending could pressure short-term profitability without guaranteeing long-term growth. Despite growth prospects in the pet insurance market, Trupanion’s high valuation, with an expected 7% revenue growth in 2025, makes it an expensive investment. Read the full article on Seeking AlphaAnalyseartikel • Oct 25
Revenues Tell The Story For Trupanion, Inc. (NASDAQ:TRUP) As Its Stock Soars 25%
Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 25% gain in the last month alone...Seeking Alpha • Sep 24
Trupanion: Great Business, But It Is Time To Cash Out (Rating Downgrade)
Summary Trupanion's stock surged over 60% since my June 2024 buy rating. Trupanion's Q2 results show strong revenue and subscription growth, with free cash flow turning positive, indicating a sustainable business model. Price hikes are essential due to rising veterinary costs and increasing anxiety claims in pets, which could impact long-term profitability if not managed. Shares are no longer a buy, and I reiterate my $40 price target with a hold rating now. Read the full article on Seeking AlphaAnalyseartikel • Aug 11
Trupanion, Inc. (NASDAQ:TRUP) Just Reported And Analysts Have Been Lifting Their Price Targets
It's been a pretty great week for Trupanion, Inc. ( NASDAQ:TRUP ) shareholders, with its shares surging 14% to US$38.30...Analyseartikel • Jul 31
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 27% gain in the last month alone...Seeking Alpha • Jun 13
Trupanion: Growth First, Profitability Second
Summary Trupanion is a global pet insurance company. Trupanion may be headed for profitability, with the new CEO emphasizing efficiency and free cash flow. The company offers pet insurance through subscriptions, focusing on growth first and profits later. Shares are a buy with a price target of $40. Read the full article on Seeking AlphaAnalyseartikel • Feb 16
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Despite an already strong run, Trupanion, Inc. ( NASDAQ:TRUP ) shares have been powering on, with a gain of 27% in the...Seeking Alpha • Feb 02
Trupanion: After All This Time, No Profits
Summary Pet insurance industry has seen significant growth due to the rising trend of millennials and Gen Z preferring pets over having children. Trupanion, a pet insurance company, has experienced wild revenue growth but struggles with increasing costs and negative margins. The company's balance sheet is not heavily burdened with liabilities, but profitability hinges on stabilizing operating expenses and addressing veterinary price hikes. Read the full article on Seeking AlphaAnalyseartikel • Dec 18
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Trupanion, Inc. ( NASDAQ:TRUP ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...Analyseartikel • Apr 18
What You Can Learn From Trupanion, Inc.'s (NASDAQ:TRUP) P/SAfter Its 35% Share Price Crash
The Trupanion, Inc. ( NASDAQ:TRUP ) share price has fared very poorly over the last month, falling by a substantial...Aktionärsrenditen
| TRUP | US Insurance | US Markt | |
|---|---|---|---|
| 7D | -13.2% | -2.6% | -0.2% |
| 1Y | -42.5% | 2.9% | 14.8% |
Rendite im Vergleich zur Industrie: TRUP unter dem Niveau der Branche US Insurance , die im vergangenen Jahr eine Rendite von 2.9% erzielte.
Rendite vs. Markt: TRUP hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 14.8 erzielte.
Preisvolatilität
| TRUP volatility | |
|---|---|
| TRUP Average Weekly Movement | 8.1% |
| Insurance Industry Average Movement | 4.8% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stabiler Aktienkurs: TRUP hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: TRUPDie wöchentliche Volatilität (8%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 2000 | 1,121 | Margi Tooth | www.trupanion.com |
Trupanion, Inc. bietet zusammen mit seinen Tochtergesellschaften in den Vereinigten Staaten, Kanada und Kontinentaleuropa Krankenversicherungen für Katzen und Hunde auf Abonnementbasis an. Das Unternehmen ist in zwei Geschäftsbereichen tätig: dem Abonnementgeschäft und dem sonstigen Geschäft. Es richtet sich an Tierhalter und Tierärzte.
Trupanion, Inc.'s Grundlagenzusammenfassung
| TRUP grundlegende Statistiken | |
|---|---|
| Marktanteil | US$1.09b |
| Gewinn(TTM) | US$23.21m |
| Umsatz(TTM) | US$1.52b |
47.2x
Kurs-Gewinn-Verhältnis 0.7x
Kurs-Umsatz-VerhältnisIst TRUP zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| TRUP Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$1.52b |
| Kosten der Einnahmen | US$1.18b |
| Bruttogewinn | US$343.44m |
| Sonstige Ausgaben | US$320.23m |
| Gewinn | US$23.21m |
Zuletzt gemeldete Gewinne
Jun 30, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 0.53 |
| Bruttomarge | 22.58% |
| Nettogewinnspanne | 1.53% |
| Schulden/Eigenkapital-Verhältnis | 26.1% |
Wie hat sich TRUP auf lange Sicht entwickelt?
Historische Performance und VergleicheUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/09/10 01:38 |
| Aktienkurs zum Tagesende | 2026/09/10 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das , das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Trupanion, Inc. wird von 16 Analysten beobachtet. 5 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Christopher Merwin | Barclays |
| Joshua Shanker | BofA Global Research |
| Ryan Tunis | Cantor Fitzgerald & Co. |